PIM KINASE INHIBITOR IN COMBINATION WITH KRAS INHIBITOR - NINGBO NEWBAY TECH DEVELOPMENT CO LTD

Title:

PIM KINASE INHIBITOR IN COMBINATION WITH KRAS INHIBITOR

Document Type and Number:

WIPO Patent Application WO/2024/082724

Kind Code:

A1

Abstract:

It relates to the combination of PIM kinase inhibitor and a KRAS inhibitor for use in treating cancer, in a subject in need thereof. Also provided are compositions or kits comprising same. Furthermore, it also relates to a PIM kinase inhibitor for use in treating cancer with KRAS mutation in a human subject in need thereof.

More Like This:

JP6453231	Urea derivatives, or pharmacologically acceptable salts thereof
JP2013533258	Compounds to inhibit cell growth
WO/2017/106568	COMBINATION OF A JAK INHIBITOR AND A BROMODOMAIN INHIBITOR FOR TREATING CANCER

Inventors:

XU YANHUA (CN)
LIN KUI (CN)
SHEN ZHENHAI (CN)

Application Number:

PCT/CN2023/107140

Publication Date:

April 25, 2024

Filing Date:

July 13, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

NINGBO NEWBAY TECH DEVELOPMENT CO LTD (CN)
SHANGHAI NEWBAY MEDICAL TECH CO LTD (CN)

International Classes:

A61K31/427; A61K31/4155; A61P35/00; A61P35/04; C07D405/14; C07D417/14

Attorney, Agent or Firm:

KING & WOOD MALLESONS (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: HIGH-STRENGTH AND DUCTILITY MULTI-COMPONENT SOFT MAGNETIC ALLOY AND PREPARATION METHOD THEREFOR

Next Patent: DEVICES AND METHODS OF COMMUNICATION